This provider's $6.7M in total Medicare payments ranks in the 86th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 4126% from 2018 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 5213% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2018 | $310.71 | $82.55 | 3.76x | $228.16 | $29.3K | 347 | 347 |
| 2019 | $494.43 | $147.32 | 3.36x | $347.11 | $1.6M | 16.1K | 14.8K |
| 2020 | $513.71 | $142.11 | 3.61x | $371.60 | $1.3M | 13.4K | 12.2K |
| 2021 | $502.08 | $139.45 | 3.60x | $362.63 | $1.4M | 13.9K | 12.8K |
| 2022 | $518.84 | $142.71 | 3.64x | $376.13 | $1.2M | 11.9K | 10.7K |
| 2023 | $651.28 | $215.01 | 3.03x | $436.27 | $1.2M | 11.6K | 10.7K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81450 | Test for detecting genes associated with blood related cancer | 1.0K | $763.5K | $751.46 | 5.66x |
| 81206 | Translocation analysis (BCR/ABL1) minor breakpoint | 3.3K | $554.5K | $166.13 | 3.75x |
| 81207 | Translocation analysis (BCR/ABL1) major breakpoint | 3.3K | $490.3K | $146.75 | 3.75x |
| 88237 | Tissue culture for tumor disorders of bone marrow and blood cells | 3.5K | $488.4K | $141.31 | 4.19x |
| 88264 | Chromosome analysis for genetic defects | 3.1K | $437.5K | $141.73 | 4.08x |
| 88184 | Flow cytometry technique for DNA or cell analysis | 6.1K | $368.9K | $60.46 | 5.62x |
| 81235 | Gene analysis (epidermal growth factor receptor), common variants | 1.1K | $356.6K | $320.65 | 4.73x |
| 88377 | Microscopic genetic examination manual | 1.8K | $315.6K | $175.44 | 2.73x |
| 88360 | Microscopic genetic analysis of tumor | 4.9K | $293.6K | $59.70 | 3.26x |
| 81210 | Gene analysis (v-raf murine sarcoma viral oncogene homolog B1) | 1.6K | $279.8K | $173.37 | 2.52x |
| 88342 | Tissue or cell analysis by immunologic technique | 4.6K | $263.5K | $57.32 | 2.34x |
| 88275 | Genetic testing | 4.5K | $224.1K | $49.75 | 4.14x |
| 81270 | Gene analysis (Janus kinase 2) variant | 1.9K | $172.6K | $92.77 | 2.45x |
| 88341 | Special stained specimen slides to examine tissue | 3.1K | $159.0K | $51.52 | 2.51x |
| 81275 | Gene analysis (v-Ki-ras2 Kirsten rat sarcoma viral oncogene) variants in codons 12 and 13 | 767 | $146.5K | $190.96 | 2.17x |
| 81455 | Targeted genomic sequence analysis panel of dna or combine dna and rna of 51 or greater genes associated with blood and lymphatic system disorders | 51 | $145.9K | $2.9K | 1.52x |
| 81276 | Gene analysis (Kirsten rat sarcoma viral oncogene homolog), additional variants | 755 | $144.1K | $190.82 | 2.13x |
| 88185 | Flow cytometry technique for DNA or cell analysis | 6.0K | $124.1K | $20.51 | 5.72x |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | 2.2K | $121.8K | $56.34 | 2.78x |
| 81219 | Gene analysis (calreticulin), common variants | 941 | $115.9K | $123.11 | 4.86x |
This provider submits charges 3.88 times higher than what Medicare actually pays.
A markup ratio of 3.88x means for every $100 Medicare pays, this provider initially charges $388. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CT for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Dianon Systems, Inc | Shelton, CT | $71.6M | ✓ Clear |
| Quest Diagnostics Llc | Wallingford, CT | $45.8M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data